Biotech
-
80CytoDyn FDA Letter is Old News – International Still Progressing
CytoDyn Inc (OTCMKTS: CYDY) shareholders got a real gut check yesterday as the STAT writer Adam Feuerstein sent out a tweet at...
-
5.0KRGBP Stock: Nickel, Dime, Quarter, Dollars
The one OTC stock that needs to be on every investor’s radar right now is Regen BioPharma (OTCMKTS: RGBP). We alerted our...
-
1371Northwest Biotherapeutics Breadcrumbs Point to ASCO Announcement of Top Line Data
For months, shareholders in Northwest Biotherapeutics (OTCMKTS: NWBO) have been speculating on the message boards about the timing of the release o...
-
2.6KCytoDyn’s Adjust Course to Emphasize Philippine EUA and Long Haulers
Many CytoDyn Inc. (OTCMKTS: CYDY) shareholders have been waiting impatiently for an EUA from the US FDA and a BLA in HIV. ...
-
612Kempharm (KMPH) Shareholders Blinded by Short Term Greed Versus Solid Long Term Outlook
The ADHD market is over $10B yearly in the US. Last week, Kempharm (NASDAQ: KMPH) announced a very positive restructuring of their...
-
8.4KRegen BioPharma About To Become A Major Pharma Player
The entire OTC Market is talking about just one stock this week and that’s Regen BioPharma (OTCMKTS: RGBP). The stock rocketed 957% in...
-
87CytoDyn Doubles Down on Revenue and EUA Strategy with Philippines Announcement
CytoDyn Inc. (OTCMKTS: CYDY) announced yesterday that it shipped 28 doses of leronlimab under Compassionate Special Permit (CSP) to one hospital in...
-
2.4KCOVID Stocks Popping in Sympathy with Positive Humanigen Top Line Data
Humanigen Inc. (NASDAQ: HGEN) released excellent news that their drug lenzilumab improved survival without the need for invasive mechanical ventila...
-
891CytoDyn’s Smoking Gun For an Immediate EUA
The controversy surrounding CytoDyn Inc. (OTCMKTS: CYDY) stock is startling. An aggressive pack of short sellers claim its leronlimab Covid trial...
-
1143CytoDyn Saves Lives & Reduces COVID-19 Hospital Duration
6 endpoints met after full data release so shorts double down on trial failure narrative Investors in CytoDyn Inc. (OTCMKTS: CYDY) are...